Connor, Clark & Lunn Investment Management (CC&L)
DNTH icon

Connor, Clark & Lunn Investment Management (CC&L)’s Dianthus Therapeutics DNTH Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,738
Closed -$29.9K – 1296
2022
Q4 		$29.9K Sell
4,738
-676
-12% -$4.27K ﹤0.01% 1161
2022
Q3 		$122K Buy
5,414
+3,338
+161% +$75.2K ﹤0.01% 1030
2022
Q2 		$40K Buy
+2,076
New +$40K ﹤0.01% 1012